DPY19L1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.576600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.379400E-01
Normal-vs-Stage2
3.983200E-01
Normal-vs-Stage3
9.962800E-01
Normal-vs-Stage4
3.596600E-01
Stage1-vs-Stage2
5.705600E-01
Stage1-vs-Stage3
6.535400E-01
Stage1-vs-Stage4
7.891200E-01
Stage2-vs-Stage3
3.305800E-01
Stage2-vs-Stage4
8.501600E-01
Stage3-vs-Stage4
4.837800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.952600E-01
Normal-vs-AfricanAmerican
3.331400E-01
Normal-vs-Asian
4.064200E-01
Caucasian-vs-AfricanAmerican
5.984000E-01
Caucasian-vs-Asian
8.463400E-01
AfricanAmerican-vs-Asian
7.709400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.360800E-01
Normal-vs-Female
3.810600E-01
Male-vs-Female
2.229800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.468400E-01
Normal-vs-Age(41-60Yrs)
2.337800E-01
Normal-vs-Age(61-80Yrs)
5.803600E-01
Normal-vs-Age(81-100Yrs)
5.693600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.520760E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.217400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.165200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.907800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.847010E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.857400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.543600E-01
Normal-vs-Daily Drinker
7.847800E-01
Normal-vs-Weekly Drinker
3.909800E-01
Normal-vs-Occasional Drinker
1.063590E-01
Normal-vs-Social Drinker
3.766000E-01
Non Drinker-vs-Daily Drinker
9.312800E-01
Non Drinker-vs-Weekly Drinker
1.310380E-01
Non Drinker-vs-Occasional Drinker
2.295200E-01
Non Drinker-vs-Social Drinker
1.206820E-01
Daily Drinker-vs-Weekly Drinker
2.426600E-01
Daily Drinker-vs-Occasional Drinker
2.787200E-01
Daily Drinker-vs-Social Drinker
2.295600E-01
Weekly Drinker-vs-Occasional Drinker
9.680800E-01
Weekly Drinker-vs-Social Drinker
9.960800E-01
Occasional Drinker-vs-Social Drinker
9.707000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.528400E-01
Normal-vs-Grade 2
1.710010E-01
Normal-vs-Grade 3
1.895760E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.172200E-02
Grade 1-vs-Grade 3
2.648000E-02
Grade 1-vs-Grade 4
5.528400E-01
Grade 2-vs-Grade 3
6.416200E-01
Grade 2-vs-Grade 4
1.710010E-01
Grade 3-vs-Grade 4
1.895760E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.401000E-01
Normal-vs-NonDiabetic
4.181000E-01
Diabetic-vs-NonDiabetic
1.487190E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.339800E-01
Normal-vs-NoPancreatitis
5.045600E-01
Pancreatitis-vs-NoPancreatitis
9.577400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.493000E-01
Normal-vs-N1
3.698400E-01
N0-vs-N1
1.097220E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.421000E-01
Normal-vs-TP53-NonMutant
7.788800E-01
TP53-Mutant-vs-TP53-NonMutant
1.697610E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
